ModiQuest Research has extensive knowledge and experience of antibody technologies.
With state-of-the-art facilities and proprietary tools, ModiQuest Research supports the development and production of antibody-based therapies and diagnostics in the most efficient and cost effective way possible.
Established since 2005 ModiQuest Research is based in Nijmegen, The Netherlands, with a global customer base that includes small and large leading pharmaceutical and diagnostic companies as well as academic research teams.
ModiQuest B.V is a sister company that develops new antibody therapies and diagnostics for rheumatoid arthritis and inflammatory disorders.